Andan, Althea B.
HRN: 26-51-69 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/13/2025
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
01/13/2025
01/20/2025
IV DRIP OVER 30 MINS
380 MG
Q6HRS
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes